This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Coherus BioSciences (CHRS) upgraded to Buy from Neutral at UBS; tgt $11
> Otsuka (OTSKY) upgraded to Buy from Hold at Jefferies
> William Demant Holding (WILYY) upgraded to Equal-Weight from Underweight at Morgan Stanley
Downgrades:
> JBS SA (JBSAY) downgraded to Equal Weight from Overweight at Barclays
Others:
> Restaurant Brands Int’l (QSR) assumed with a Sector Outperform at Scotiabank; tgt $72
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.
Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.